January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Neutrolis
Neutrolis is developing first-in-class therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs), a newly discovered innate immune pathway.
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)